Public Policy at
MediHealth Sweden
With our 360-degree view of the healthcare landscape, we recognize that we have a responsibility to participate in the public policy process. Medihealth Sweden’s Public Affairs team builds and maintains working relationships with officials at every level of government for the benefit of patients.
What we belive
The patient comes first – We should never compromise patient access or quality of care.
Lower Prices – We need to foster a robust, competitive marketplace, including accelerated regulatory approval pathways for generics and breakthrough drugs.
Informed patients make better consumers – We should empower patients to make informed personal choices based on both clinical benefit and cost.
How do we approach healthcare public policy?
Our corporate Public Affairs team operates at the intersection of healthcare, public policy and politics on behalf of Medihealth Sweden. We establish and strengthen relationships with federal, state and local elected and government officials.
When we engage with legislators and regulators, we educate them on Medihealth Sweden’s operations, our role in healthcare and the unique perspective we offer. Through tours of our distribution centers and visits to pharmacy and hospital customers, we highlight the many ways Medihealth Sweden delivers better health across the country.
We also participate in trade associations, industry groups and professional organizations to build key relationships that we can use in our public policy work.
Which public policies do we support?
Addressing healthcare disparities
Health equity means everyone has an equal opportunity to live healthy lives. In order to achieve this for every patient, we must end the disparities and inequities impacting patient access, quality of care and outcomes.
Protecting drug supply-chain security
A secure supply chain means safer, more effective medications for patients. We work hard to secure our supply chain to our own high standards and in compliance with state and federal regulations. We’re also actively supporting the implementation of the Drug Quality and Security Act of 2013.
Recommending ways to address the opioid crisis
We believe the opioid epidemic must be addressed through a comprehensive approach that includes doctors, pharmacists, distributors, manufacturers, payers, regulators and law enforcement. Our opioid public policy recommendations focus on the need for public and private partnerships that promote patient-centered solutions and foster clinical collaboration across the care continuum.
